Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1961 1
1964 1
1965 2
1966 4
1968 2
1969 2
1970 1
1971 5
1972 7
1973 3
1974 5
1975 2
1977 7
1978 1
1979 5
1980 5
1981 2
1982 7
1983 3
1984 7
1985 2
1986 6
1987 8
1988 10
1989 2
1990 4
1991 7
1992 6
1993 7
1994 3
1995 1
1996 3
1997 5
1998 4
1999 2
2000 1
2001 3
2003 3
2004 5
2005 6
2006 4
2007 5
2008 8
2009 13
2010 19
2011 4
2012 11
2013 15
2014 13
2015 9
2016 11
2017 17
2018 9
2019 14
2020 12
2021 12
2022 15
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

330 results

Results by year

Filters applied: . Clear all
Page 1
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study.
Kimura S, Toyoda K, Yoshimura S, Minematsu K, Yasaka M, Paciaroni M, Werring DJ, Yamagami H, Nagao T, Yoshimura S, Polymeris A, Zietz A, Engelter ST, Kallmünzer B, Cappellari M, Chiba T, Yoshimoto T, Shiozawa M, Kitazono T, Koga M; SAMURAI, RELAXED, RAF, RAF-NOAC, CROMIS-2, NOACISP LONGTERM, Erlangen Registry and Verona Registry Investigators. Kimura S, et al. Stroke. 2022 May;53(5):1540-1549. doi: 10.1161/STROKEAHA.121.036695. Epub 2022 Feb 2. Stroke. 2022. PMID: 35105180 Free PMC article.
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
Toyoda K, Uchiyama S, Yamaguchi T, Easton JD, Kimura K, Hoshino H, Sakai N, Okada Y, Tanaka K, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Isobe M, Minematsu K; CSPS.com Trial Investigators. Toyoda K, et al. Lancet Neurol. 2019 Jun;18(6):539-548. doi: 10.1016/S1474-4422(19)30148-6. Lancet Neurol. 2019. PMID: 31122494 Clinical Trial.
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
Taguchi I, Iimuro S, Iwata H, Takashima H, Abe M, Amiya E, Ogawa T, Ozaki Y, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Miyauchi K, Yamazaki T, Ito H, Otsuji Y, Kimura K, Takahashi J, Hirayama A, Yokoi H, Kitagawa K, Urabe T, Okada Y, Terayama Y, Toyoda K, Nagao T, Matsumoto M, Ohashi Y, Kaneko T, Fujita R, Ohtsu H, Ogawa H, Daida H, Shimokawa H, Saito Y, Kimura T, Inoue T, Matsuzaki M, Nagai R. Taguchi I, et al. Among authors: terayama y. Circulation. 2018 May 8;137(19):1997-2009. doi: 10.1161/CIRCULATIONAHA.117.032615. Circulation. 2018. PMID: 29735587 Free PMC article. Clinical Trial.
Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
Nishiyama Y, Kimura K, Otsuka T, Toyoda K, Uchiyama S, Hoshino H, Sakai N, Okada Y, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Minematsu K, Matsumoto M, Tominaga T, Tomimoto H, Terayama Y, Yasuda S, Yamaguchi T; CSPS.com Trial Investigators. Nishiyama Y, et al. Among authors: terayama y. Stroke. 2023 Mar;54(3):697-705. doi: 10.1161/STROKEAHA.122.039900. Epub 2023 Feb 3. Stroke. 2023. PMID: 36734235 Clinical Trial.
Nonresponder Considerations for Romosozumab Treatment.
Tominaga A, Wada K, Okazaki K, Nishi H, Terayama Y, Shimamoto S, Kodama Y, Kato Y. Tominaga A, et al. Among authors: terayama y. Calcif Tissue Int. 2023 Aug;113(2):157-165. doi: 10.1007/s00223-023-01087-y. Epub 2023 May 3. Calcif Tissue Int. 2023. PMID: 37138124
[Seizure].
Saito A, Terayama Y. Saito A, et al. Among authors: terayama y. Nihon Rinsho. 2013 Jun;71(6):1009-13. Nihon Rinsho. 2013. PMID: 23855204 Review. Japanese.
Dashcam-captured moment of right hemispheric stroke.
Miyazawa H, Terayama Y. Miyazawa H, et al. Among authors: terayama y. J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105094. doi: 10.1016/j.jstrokecerebrovasdis.2020.105094. Epub 2020 Jul 4. J Stroke Cerebrovasc Dis. 2020. PMID: 32807488
Association Between Frequency of Social Contact and Brain Atrophy in Community-Dwelling Older People Without Dementia: The JPSC-AD Study.
Hirabayashi N, Honda T, Hata J, Furuta Y, Shibata M, Ohara T, Tatewaki Y, Taki Y, Nakaji S, Maeda T, Ono K, Mimura M, Nakashima K, Iga JI, Takebayashi M, Ninomiya T; as the Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD) Study. Hirabayashi N, et al. Neurology. 2023 Sep 12;101(11):e1108-e1117. doi: 10.1212/WNL.0000000000207602. Epub 2023 Jul 12. Neurology. 2023. PMID: 37438128
White matter lesions in the elderly.
Meyer JS, Kawamura J, Terayama Y. Meyer JS, et al. Among authors: terayama y. J Neurol Sci. 1992 Jul;110(1-2):1-7. doi: 10.1016/0022-510x(92)90002-3. J Neurol Sci. 1992. PMID: 1506848 Review.
CKD, Brain Atrophy, and White Matter Lesion Volume: The Japan Prospective Studies Collaboration for Aging and Dementia.
Maki K, Ohara T, Hata J, Shibata M, Hirabayashi N, Honda T, Sakata S, Furuta Y, Akiyama M, Yamasaki K, Tatewaki Y, Taki Y, Kitazono T, Mikami T, Maeda T, Ono K, Mimura M, Nakashima K, Iga JI, Takebayashi M, Ninomiya T; Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD) study group. Maki K, et al. Kidney Med. 2022 Dec 23;5(3):100593. doi: 10.1016/j.xkme.2022.100593. eCollection 2023 Mar. Kidney Med. 2022. PMID: 36874508 Free PMC article.
330 results